StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Earnings

Jaguar Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2026
$20.27M
EPS, Q1 FY2026
-$13.60
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Jaguar Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 19, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 20, 2026after the close$20.27M–-$13.60Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close–––Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025before the open$3.50M––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open$3.10M––Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024before the open$2.72M+1.6%-$4.04Release
Q2 FY2023ended Jun 30, 2023Aug 14, 2023before the open$2.68M–-$0.42Release
Q1 FY2023ended Mar 31, 2023May 15, 2023before the open–––Release
Q4 FY2022ended Dec 31, 2022Mar 27, 2023before the open$3.30M+57.1%–Release
Q3 FY2022ended Sep 30, 2022Nov 14, 2022before the open$3.15M+400.0%-$0.12Release
Q1 FY2022ended Mar 31, 2022May 10, 2022before the open$2.63M–-$0.40Release
Q4 FY2021ended Dec 31, 2021Mar 11, 2022after the close$2.10M––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Jaguar Health has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Jaguar Health puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Jaguar Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Update
  6. Results
  7. News
  8. Update
  9. Update
  10. Update
  11. Update
  12. Results
  13. Update
  14. Update
  15. Results

See a number that looks wrong?